Orchard Therapeutics PLC Sponsored ADR Net Profit Margin 2019-2023 | ORTX
Orchard Therapeutics PLC Sponsored ADR net profit margin from 2019 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
Net Profit Margin Historical Data |
Date |
TTM Revenue |
TTM Net Income |
Net Margin |
2023-09-30 |
$0.02B |
$-0.07B |
-342.86% |
2023-06-30 |
$0.02B |
$-0.09B |
-404.76% |
2023-03-31 |
$0.02B |
$-0.12B |
-688.89% |
2022-12-31 |
$0.02B |
$-0.15B |
-656.52% |
2022-09-30 |
$0.02B |
$-0.18B |
-1118.75% |
2022-06-30 |
$0.01B |
$-0.17B |
-1518.18% |
2020-09-30 |
$0.00B |
$-0.16B |
-4100.00% |
2020-06-30 |
$0.00B |
$-0.18B |
-4525.00% |
2019-09-30 |
$0.00B |
$-0.14B |
-4800.00% |